Abbott’s continuous glucose monitoring system, the FreeStyle Libre 2, has been approved in Canada for adults and children four years and older with diabetes. The FreeStyle Libre 2 system continuously ...
Diabetes Care and CamDiab are pleased to announce that Health Canada has approved the use of mylife Loop powered by mylife ...
Abbott’s (NYSE: ABT) newest sensor-based glucose technology, the FreeStyle Libre 3 Plus* sensor, is now publicly funded in every province across ...
(RTTNews) - Abbott Laboratories (ABT), Wednesday announced that its sensor-based glucose technology, the FreeStyle Libre 3 Plus sensor, is now publicly funded in every province across Canada, meaning ...
NEW YORK -- The weight loss drug Meridia is being be pulled off the market in Canada, the nation's health department said Friday, because of links to side effects like heart attacks and strokes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback